Endogenous Radionanomedicine: Validation of Therapeutic Potential View Full Text


Ontology type: schema:Chapter     


Chapter Info

DATE

2018-05-26

AUTHORS

Seunggyun Ha , Dong Soo Lee

ABSTRACT

Exosomes have features to be able to promise therapeutic opportunities, which are exosomes-mediated pathogenesis in certain diseases, and thus their inherent therapeutic potential, and again possibility of use of exosomes as drug carriers. There have been increasing interests in this therapeutic potential of exosomes owing to the recent reports in regenerative medicine, tumor management, infection, and organ transplantation. Radionanomedicines i.e. radiolabeled exosomes provide advantages of non-invasive, less toxic, highly penetrable, highly sensitive, and quantification-enabling characteristic of radioactivity for validation of therapeutic potentials of exosomes. Radiolabeled exosomes are expected to allow their theranostic use even in clinical settings. However, there remain the issues to overcome the low yields of exosomes, release of free radioisotope after degradation of exosomes, and yet unveiled dosimetry of therapeutic radiolabeled exosomes. This chapter reviews current evidences of therapeutic applications of exosomes in regenerative medicine and tumor management and discusses radiolabeled exosomes or exosome-mimetic nanovesicles as well as remaining issues in endogenous radionanomedicines regarding the desired therapeutic potentials of radiolabeled or unlabeled exosomes. More... »

PAGES

167-182

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/978-3-319-67720-0_9

DOI

http://dx.doi.org/10.1007/978-3-319-67720-0_9

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1104229759


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1107", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Immunology", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, 03080, Seoul, Republic of Korea", 
          "id": "http://www.grid.ac/institutes/grid.31501.36", 
          "name": [
            "Department of Nuclear Medicine, Seoul National University College of Medicine, 03080, Seoul, Republic of Korea", 
            "Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, 03080, Seoul, Republic of Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ha", 
        "givenName": "Seunggyun", 
        "id": "sg:person.01107464404.68", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01107464404.68"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Korea Brain Research Institute, Daegu, Republic of Korea", 
          "id": "http://www.grid.ac/institutes/grid.452628.f", 
          "name": [
            "Department of Nuclear Medicine, Seoul National University College of Medicine, 03080, Seoul, Republic of Korea", 
            "Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, 03080, Seoul, Republic of Korea", 
            "Korea Brain Research Institute, Daegu, Republic of Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lee", 
        "givenName": "Dong Soo", 
        "id": "sg:person.015617314175.88", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015617314175.88"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2018-05-26", 
    "datePublishedReg": "2018-05-26", 
    "description": "Exosomes have features to be able to promise therapeutic opportunities, which are exosomes-mediated pathogenesis in certain diseases, and thus their inherent therapeutic potential, and again possibility of use of exosomes as drug carriers. There have been increasing interests in this therapeutic potential of exosomes owing to the recent reports in regenerative medicine, tumor management, infection, and organ transplantation. Radionanomedicines i.e. radiolabeled exosomes provide advantages of non-invasive, less toxic, highly penetrable, highly sensitive, and quantification-enabling characteristic of radioactivity for validation of therapeutic potentials of exosomes. Radiolabeled exosomes are expected to allow their theranostic use even in clinical settings. However, there remain the issues to overcome the low yields of exosomes, release of free radioisotope after degradation of exosomes, and yet unveiled dosimetry of therapeutic radiolabeled exosomes. This chapter reviews current evidences of therapeutic applications of exosomes in regenerative medicine and tumor management and discusses radiolabeled exosomes or exosome-mimetic nanovesicles as well as remaining issues in endogenous radionanomedicines regarding the desired therapeutic potentials of radiolabeled or unlabeled exosomes.", 
    "editor": [
      {
        "familyName": "Lee", 
        "givenName": "Dong Soo", 
        "type": "Person"
      }
    ], 
    "genre": "chapter", 
    "id": "sg:pub.10.1007/978-3-319-67720-0_9", 
    "isAccessibleForFree": false, 
    "isPartOf": {
      "isbn": [
        "978-3-319-67719-4", 
        "978-3-319-67720-0"
      ], 
      "name": "Radionanomedicine", 
      "type": "Book"
    }, 
    "keywords": [
      "therapeutic potential", 
      "tumor management", 
      "inherent therapeutic potential", 
      "organ transplantation", 
      "current evidence", 
      "therapeutic opportunities", 
      "clinical setting", 
      "exosome-mimetic nanovesicles", 
      "certain diseases", 
      "exosomes", 
      "recent reports", 
      "theranostic use", 
      "therapeutic applications", 
      "regenerative medicine", 
      "medicine", 
      "transplantation", 
      "pathogenesis", 
      "infection", 
      "disease", 
      "management", 
      "report", 
      "drug carriers", 
      "radioactivity", 
      "setting", 
      "use", 
      "release", 
      "evidence", 
      "potential", 
      "nanovesicles", 
      "dosimetry", 
      "validation", 
      "radioisotopes", 
      "i.", 
      "carriers", 
      "features", 
      "possibility of use", 
      "characteristics", 
      "radionanomedicine", 
      "possibility", 
      "issues", 
      "opportunities", 
      "interest", 
      "chapter", 
      "low yield", 
      "advantages", 
      "degradation", 
      "discusses", 
      "applications", 
      "yield"
    ], 
    "name": "Endogenous Radionanomedicine: Validation of Therapeutic Potential", 
    "pagination": "167-182", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1104229759"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/978-3-319-67720-0_9"
        ]
      }
    ], 
    "publisher": {
      "name": "Springer Nature", 
      "type": "Organisation"
    }, 
    "sameAs": [
      "https://doi.org/10.1007/978-3-319-67720-0_9", 
      "https://app.dimensions.ai/details/publication/pub.1104229759"
    ], 
    "sdDataset": "chapters", 
    "sdDatePublished": "2022-10-01T06:57", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/chapter/chapter_357.jsonl", 
    "type": "Chapter", 
    "url": "https://doi.org/10.1007/978-3-319-67720-0_9"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/978-3-319-67720-0_9'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/978-3-319-67720-0_9'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/978-3-319-67720-0_9'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/978-3-319-67720-0_9'


 

This table displays all metadata directly associated to this object as RDF triples.

121 TRIPLES      22 PREDICATES      72 URIs      65 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/978-3-319-67720-0_9 schema:about anzsrc-for:11
2 anzsrc-for:1107
3 schema:author N9802bd0d85e44c3790906f92c4d4c9d4
4 schema:datePublished 2018-05-26
5 schema:datePublishedReg 2018-05-26
6 schema:description Exosomes have features to be able to promise therapeutic opportunities, which are exosomes-mediated pathogenesis in certain diseases, and thus their inherent therapeutic potential, and again possibility of use of exosomes as drug carriers. There have been increasing interests in this therapeutic potential of exosomes owing to the recent reports in regenerative medicine, tumor management, infection, and organ transplantation. Radionanomedicines i.e. radiolabeled exosomes provide advantages of non-invasive, less toxic, highly penetrable, highly sensitive, and quantification-enabling characteristic of radioactivity for validation of therapeutic potentials of exosomes. Radiolabeled exosomes are expected to allow their theranostic use even in clinical settings. However, there remain the issues to overcome the low yields of exosomes, release of free radioisotope after degradation of exosomes, and yet unveiled dosimetry of therapeutic radiolabeled exosomes. This chapter reviews current evidences of therapeutic applications of exosomes in regenerative medicine and tumor management and discusses radiolabeled exosomes or exosome-mimetic nanovesicles as well as remaining issues in endogenous radionanomedicines regarding the desired therapeutic potentials of radiolabeled or unlabeled exosomes.
7 schema:editor N1518ac51a5d14ba19677ac39d5612b87
8 schema:genre chapter
9 schema:isAccessibleForFree false
10 schema:isPartOf N5526d2d435844220bff681dcd255d5ea
11 schema:keywords advantages
12 applications
13 carriers
14 certain diseases
15 chapter
16 characteristics
17 clinical setting
18 current evidence
19 degradation
20 discusses
21 disease
22 dosimetry
23 drug carriers
24 evidence
25 exosome-mimetic nanovesicles
26 exosomes
27 features
28 i.
29 infection
30 inherent therapeutic potential
31 interest
32 issues
33 low yield
34 management
35 medicine
36 nanovesicles
37 opportunities
38 organ transplantation
39 pathogenesis
40 possibility
41 possibility of use
42 potential
43 radioactivity
44 radioisotopes
45 radionanomedicine
46 recent reports
47 regenerative medicine
48 release
49 report
50 setting
51 theranostic use
52 therapeutic applications
53 therapeutic opportunities
54 therapeutic potential
55 transplantation
56 tumor management
57 use
58 validation
59 yield
60 schema:name Endogenous Radionanomedicine: Validation of Therapeutic Potential
61 schema:pagination 167-182
62 schema:productId N1fe50378d5ea46208c29efd6214d20bb
63 N79d5501e1ea84b01926739a4765eb49f
64 schema:publisher Nd2a500d4201b44138fa1a3abe6a1764b
65 schema:sameAs https://app.dimensions.ai/details/publication/pub.1104229759
66 https://doi.org/10.1007/978-3-319-67720-0_9
67 schema:sdDatePublished 2022-10-01T06:57
68 schema:sdLicense https://scigraph.springernature.com/explorer/license/
69 schema:sdPublisher N1ed538aec58142c5a066a91b6e452743
70 schema:url https://doi.org/10.1007/978-3-319-67720-0_9
71 sgo:license sg:explorer/license/
72 sgo:sdDataset chapters
73 rdf:type schema:Chapter
74 N1518ac51a5d14ba19677ac39d5612b87 rdf:first N2f9600a8b1684b8db090ff9aae60fcaa
75 rdf:rest rdf:nil
76 N1ed538aec58142c5a066a91b6e452743 schema:name Springer Nature - SN SciGraph project
77 rdf:type schema:Organization
78 N1fe50378d5ea46208c29efd6214d20bb schema:name doi
79 schema:value 10.1007/978-3-319-67720-0_9
80 rdf:type schema:PropertyValue
81 N2f9600a8b1684b8db090ff9aae60fcaa schema:familyName Lee
82 schema:givenName Dong Soo
83 rdf:type schema:Person
84 N4b6bed24a25a4704b43540da33da73b9 rdf:first sg:person.015617314175.88
85 rdf:rest rdf:nil
86 N5526d2d435844220bff681dcd255d5ea schema:isbn 978-3-319-67719-4
87 978-3-319-67720-0
88 schema:name Radionanomedicine
89 rdf:type schema:Book
90 N79d5501e1ea84b01926739a4765eb49f schema:name dimensions_id
91 schema:value pub.1104229759
92 rdf:type schema:PropertyValue
93 N9802bd0d85e44c3790906f92c4d4c9d4 rdf:first sg:person.01107464404.68
94 rdf:rest N4b6bed24a25a4704b43540da33da73b9
95 Nd2a500d4201b44138fa1a3abe6a1764b schema:name Springer Nature
96 rdf:type schema:Organisation
97 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
98 schema:name Medical and Health Sciences
99 rdf:type schema:DefinedTerm
100 anzsrc-for:1107 schema:inDefinedTermSet anzsrc-for:
101 schema:name Immunology
102 rdf:type schema:DefinedTerm
103 sg:person.01107464404.68 schema:affiliation grid-institutes:grid.31501.36
104 schema:familyName Ha
105 schema:givenName Seunggyun
106 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01107464404.68
107 rdf:type schema:Person
108 sg:person.015617314175.88 schema:affiliation grid-institutes:grid.452628.f
109 schema:familyName Lee
110 schema:givenName Dong Soo
111 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015617314175.88
112 rdf:type schema:Person
113 grid-institutes:grid.31501.36 schema:alternateName Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, 03080, Seoul, Republic of Korea
114 schema:name Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, 03080, Seoul, Republic of Korea
115 Department of Nuclear Medicine, Seoul National University College of Medicine, 03080, Seoul, Republic of Korea
116 rdf:type schema:Organization
117 grid-institutes:grid.452628.f schema:alternateName Korea Brain Research Institute, Daegu, Republic of Korea
118 schema:name Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, 03080, Seoul, Republic of Korea
119 Department of Nuclear Medicine, Seoul National University College of Medicine, 03080, Seoul, Republic of Korea
120 Korea Brain Research Institute, Daegu, Republic of Korea
121 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...